Author | Country and setting | Type of study and duration of data collection | Population | AMS development | Intervention type | Outcome description |
---|---|---|---|---|---|---|
Hall et al. [34] | Tanzania, Tertiary Care Hospital | Qualitative Study January 2017–December 2018 | Adult medicine and paediatric wards | 1. Baseline Clinician Survey on knowledge of AMS/AMR 2. Chart review of antimicrobial prescribing practices 3. Baseline audit of bacterial species and Antimicrobial Resistance Patterns 4. Local pharmacy survey Creating an AMS guidebook focused on the common organisms isolated in that location. Guidebook covering empirical antibiotic coverage based on resistance patterns, availability of the antibiotics and the national guidelines. Guidebook to be electronically distributed | Enabling | No outcome |
Joshi et al. [27] | Nepal, Tertiary Care Hospital | Controlled Interrupted Time Series August 2016–August 2017 | Adults over 15 years in medical, surgical and obstetric wards | 1. Laboratory surveillance for baseline 2. Antibiotic prescribing guidelines based on common infections and drug availability 3. Post-prescription review and feedback adaptation led by physician champions in study wards, and stewardship training 4. Post-prescription review and feedback evaluation | Bundle: Persuasive and Enabling | 1. Behavioral outcomes: (A) Recommendations by physician champions were most followed and in the medicine ward 2. Clinical outcomes: (A) DOT per 1,000 PD increased from 761 to 823 (P < 0.001) for intravenous therapy, and DOT for oral therapy increased from 302 to 390 (P < 0.001) Cephalosporin use decreased from 420 DOT/1000 PD to 344 (P < 0.0001) and aminoglycoside decreased from 138 DOT/1000 PD to 95 (P < 0.001) (B) No significant difference in length of stay |
Gebretekle et al. [28] | Ethiopia, Tertiary care hospital | Controlled Interrupted Time Series November 17–January 2019 | Adult medicine and paediatric wards | 1. Adapting antimicrobial prescribing guidelines according to local common indications for antimicrobial prescription 2. Institutional microbiogram from laboratory data 3. Training pharmacists and giving AMR information sessions for clinicians 4. Pharmacists from the AMS issue a recommendation and followed up to assess acceptance or non-acceptance of the intervention | Bundle (Enabling and Persuasive) | 1. Behavioral—Reduction in antibiotic prescription without documented source during post-intervention phase (25% vs. 16%) 2. Clinical: (A) Reduction in hospital acquired Infection (78% vs. 66%) (B) Days of Therapy: Days of antibiotic therapy increased: from 8.7 ± 6.9 days during the intervention, to 12.8 ± 11.7 days post intervention for all antibiotics. A twofold increase in DOT mean DOT of 754 ± 99.8/1000 patient-days in the intervention phase to 1549 ± 175.2/1000 patient-days during the following 5 months (C) Length of Stay in hospital increased from 19.8 ± 12.0 days to 24.1 ± 13.9 (20% increase in duration, p < 0.001) (D) All-cause mortality increased from 6.9% during the intervention to 14.7% post–intervention p < 0.01 |
Ackers et al. [31] | Uganda, Tertiary Care Hospital | Qualitative Study January 2019–January 2020 | Obstetric patients | 1. Four-month baseline data on drug orders and supplies from national medical stores and dispensing log 2. Introduction of swabbing post-caesarean wounds for laboratory diagnosis of infection (culture and sensitivity) and wound cleaning (Infection prevention) 3. Laboratory data on samples from post-natal ward 4. Survey on Perceptions of the impact and effectiveness of the AMS program 5. New policy to restrict high-end antibiotics culture and sensitivity indication | Structural and restrictive | 1. Clinical: Increase in number and frequency of patient’s wounds being cleaned daily with culture and sensitivity from 0 to 95% of all suspected sepsis patients having culture and sensitivity 2. Behavioral: (A) Better patient care for women with septic wounds (B) Better collaboration among pharmacists, nurses and physicians in caring for patients 3. Procurement: Pharmacists became judicious in ordering of antibiotics using the information from the laboratory culture and sensitivity testing |
Hearn et al. [29] | Cambodia, Hospital | Controlled Before and After January15–December 2015 | Children | 1. Pre-existing hospital antimicrobial guidelines were updated and converted into a free smartphone app 2. Pre-existing Point prevalence survey supported by a clinical microbiologist | Bundle: Enabling and Persuasive | 1. Clinical: (A) Decrease in HAI incidence during surveillance period (B) Median LOS for HAI cases increased for non-HAI controls: 25 days IQR 12–37 vs 5 days IQR 3–9 2. Microbiological: (A) 81% isolates were gram negative organisms. (B) Third generation cephalosporins were ineffective against 75% of clinical isolates 3. Behavioral: Increased use of guidelines in prescribing. 75.4% of antimicrobial prescriptions were appropriate |
Gentilotti et al. [32] | Tanzania, Hospital | Controlled Before and After August 2013–August 2015 | Obstetric Patients | 1. Training in Antimicrobial resistance and appropriate prescribing 2. Developing an AMS multidisciplinary team to create and monitor AMS policies | Bundle: Enabling and Persuasive | 1. Clinical: 65% reduction in CS SSIs 2. Microbiological: Lower SSI with Pfannenstiel incision (OR 0.288; 95% CI 0.197–0.420; p < 0.001) 2. Post-op antibiotic administration decreased post intervention 3. Behavioral—Increased use of skin disinfection. Improved adherence to standard operating procedures in the theatre 4. Microbiological: (A) Increased rate of microbiologically confirmed SSI was higher in post int group (OR 2.534; 95% CI 1.435–4.475; p = 0.001). (B) Decrease in prevalence of gram-positive SSI significantly decreased (OR 0.263; 95% CI 0.126–0.548; p < 0.001) (C) Reduced MRSA prevalence (79–21.4% (OR 0.072; 95% CI 0.016–0.314; p < 0.001) (D) Increase in the prevalence gram-negative SSI (including Klebsiella and Pseudomonas.) (OR 3.800; 95% CI 1.822–7.926; p < 0.001) |
Lester et al. [30] | Malawi, Tertiary hospital | Controlled before and after, Mixed methods study | Adults only | Pre-implementation prescribing survey Antibiotic treatment guideline* booklet and app Post-implementation prescribing surveys Point-prevalence surveys with feedback to prescribers | Bundle, enabling and Persuasive | 1. Clinical: 26.5% reduction in third generation cephalosporin use 2. Reduced treatment time for ceftriaxone from 5 to 4Â days 3. No difference in mortality or length of stay |
Nauriyal et al. [25] | Nepal, Three Hospitals | Controlled Before and After January 2018–January 2019 | Adults with a burn or a wound (> 15 years) | 1. Post prescription review and feedback program 2. Baseline and post-intervention chart review | Enabling | 1. Decrease in days of therapy for penicillin, aminoglycosides, and cephalosporin 2. Decrease in days of therapy for intravenous antibiotics 3. Improved appropriate prescription, de-escalation, documentation, and adherence to treatment guidelines |
Alabi et al. [33] | Liberia | Non-controlled before and after December 2019–December 2021 | Adults and children | 1. Microbiology laboratory for culture and sensitivity 2. Multidisciplinary AMS team 3. Treatment guideline, prescriber training and three weekly AMS ward rounds | Bundle: Enabling and Structural | 1. Improved appropriate prescription 2. Challenges in adoption of prescribing guidelines: 39% in appropriate antibiotic chose, 63.5% had incorrect dose and 69% had incorrect duration 3. Use of microbiology laboratory for 79.7% of patients with infectious disease |
Nelson et al. [26] | Bangladesh and Mali | Randomized cross over study. January 2021–November 2021 | Children under 5 years | 1. Development of diarrheal aetiology prediction algorithm 2. Physicians randomised to intervention and control arm 3. Study done at three sites in Bangladesh and 4 sites in Mali | Structural | 1. No statistically significant difference in proportion of children prescribed antibiotics in intervention and control arm 2. No known adverse events from DEP tool |